Skip to main content
Log in

Glucan-induced modification of the increased susceptibility of cyclophosphamide-treated mice to Staphylococcus aureus infection

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Glucan, a β1–3-polyglucosidic component of the cell wall of Saccharomyces cerevisiae, was evaluated for its ability to modify experimentally induced S. aureus septicemia in an immunosuppressed mouse model. AKR/J mice were injected with glucan (0.45 mg), cyclophosphamide (0.6 mg), isovolumetric saline (0.5 ml), or glucan (0.45 mg) and cyclophosphamide (0.6 mg) on days −10, −7, −4 and −1 prior to intravenous challenge with 1.0×109 S. aureus on day 0.

In contrast to the significant (P<0.05) decrease in leukocytes observed in the cyclophosphamide-treated mice, the administration of glucan to cyclophosphamide-treated mice resulted in maintenance of the peripheral leukocyte counts. Furthermore, glucan, as a single pretreatment regimen, resulted in a median survival time of 12.5 days, as against only 7.5 days in the saline control group. A 1.4-day median survival was observed in mice pretreated with cyclophosphamide and subsequently challenged with S. aureus. However, when glucan and cyclophosphamide were administered together, a median survival time of 9.0 days was observed.

Histopathologic examination revealed that glucan administration inhibited the renal necrosis observed in both normal and cyclophosphamide-treated mice following staphylococcal challenge. Glucan also produced a marked reduction of hepatic pathology in cyclophosphamide-treated mice following S. aureus challenge. These data denote that glucan administration is effective in altering morbidity and mortality due to systemic S. aureus disease in cyclophosphamide-treated mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Ashworth, C. T., Di Luzio, N. R., Riggi, S. J.: A morphologic study of the effect of reticuloendothelial stimulation upon hepatic removal of minute particles from the blood of rats. Exp. Mol. Pathol. 1, 83 (1963)

    Google Scholar 

  • Burgaleta, C., Golde, D. W.: Effect of glucan on granulopoiesis and macrophage genesis in mice. Cancer Res. 37, 1734 (1977)

    Google Scholar 

  • Calabrisi, P., Parks, R. E.: Chemotherapy of neoplastic disease. In: The pharmacological basis of therapeutics, p. 1248. New York: McMillan 1975

    Google Scholar 

  • Di Luzio, N. R.: Pharmacology of the reticuloendothelial system: Accent on glucan. In: The reticuloendothelial system in health and disease, p. 412. New York: Raven Press 1976

    Google Scholar 

  • Di Luzio, N. R., Williams, D. L.: Protective effect of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice. Infect. Immun. 20 (3), 804 (1978)

    Google Scholar 

  • Di Luzio, N. R., McNamee, R. B., Browder, W. I., Williams, D. L.: Glucan: Inhibition of tumor growth and enhancement of survival in four syngeneic murine tumor models. Cancer Treat. Rep. 62 (11), 1857 (1978)

  • Fenselau, C.: Review of the metabolism and mode of action of cyclophosphamide. JAOAC 59, 1028 (1976)

    Google Scholar 

  • Gaya, H., Tattersall, M. H. N., Hutchinson, R. M., Spiers, A. S. D.: Changing patterns of infections in cancer patients. Eur. J. Cancer 9, 401 (1973)

    Google Scholar 

  • Glovsky,M. M., Di Luzio, N. R., Alenty, A., Ghekiere, L.: Complement activation by glucan. J. Reticuloendothel. Soc. 20, 54a (1976)

  • Golde, D. W., Burgaleta, C.: Glucan-activated macrophages: Functional properties and cytotoxicity against syngeneic leukemia cells. In: Immune modulation and control of neoplasia by adjuvant therapy, p. 201. New York: Raven Press 1978

    Google Scholar 

  • Hassid, W. Z., Joslyn, M. A., McCready, R. M.: The molecular constitution of insoluble polysaccharide from yeast. J. Am. Chem. Soc. 63, 295 (1941)

    Google Scholar 

  • Hoffmann, E. O., Di Luzio, N. R., Cook, J. A., McNamee, R. B., Armstrong, K.: The morphologic effects of glucan in the liver, lung, and spleen of the rat: Light and electron microscopic studies. Lab. Invest. 36, 340 (1977)

    Google Scholar 

  • Hughes, W. T.: Fatal infections in childhood leukemia. Am. J. Dis. Child. 122, 283 (1971)

    Google Scholar 

  • Hughes, W. T.: Infections in the compromised host. Adv. Intern. Med. 22, 73 (1977)

    Google Scholar 

  • Israel, L., Edelstein, R.: Treatment of cutaneous and subcutaneous metastatic tumors with intralesional glucan. In: Immune modulation and control of neoplasia by adjuvant therapy, p. 249. New York: Raven Press 1978

    Google Scholar 

  • Kokoshis, P. L., Williams, D. L., Cook, J. A., Di Luzio, N. R.: Increased resistance to Staphylococcus aureus infection and enhancement in serum lysozyme activity by glucan. Science 199, 1340 (1978)

    Google Scholar 

  • Ladisch, S., Pizzo, P. A.: Staphylococcus aureus sepsis in children with cancer. Pediatrics 61, 231 (1978)

    Google Scholar 

  • Lejeune, F. J., Delville, J., Gillet, J., Song, M., Stadtsbaeder, S., Jacques, P.: Effects of the yeast polysaccharide glucan on transplanted colon carcinoma of the rat and experimental infectious diseases: A preliminary report. Eur. J. Cancer (in press, 1978).

  • Mansell, P. W. A., Ichinose, H., Reed, R. J., Krementz, E. T., McNamee, R., Di Luzio, N. R.: Macrophage-mediated destruction of human malignant cells in vivo. J. Natl. Cancer Inst. 54, 571 (1975)

    Google Scholar 

  • Mansell, P. W. A., Di Luzio, N. R., McNamee, R., Rowden, G., Proctor, J. W.: Recognition factors and non-specific macrophage activation in the treatment of neoplastic disease. Ann. N.Y. Acad. Sci. 277, 20 (1976)

    Google Scholar 

  • Riggi, S. J., Di Luzio, N. R.: Identification of a reticuloendothelial stimulating agent in zymosan. Am. J. Physiol. 200, 297 (1961)

    Google Scholar 

  • Sharbaugh, R. T.: Cyclophosphamide-induced immunosuppression and its effect on host resistance to bacterial invasion. Univ. of Mississippi Medical Center, Doctoral Thesis, p. 57 (1969)

  • Sharbaugh, R. T., Grogan, J. B.: Suppression of reticuloendothelial function in the rat with cyclophosphamide. Infect. Immun. 100, 117 (1969)

    Google Scholar 

  • Sher, N. A., Chaparas, S. D., Greenburg, L. E., Bernard, S.: Effects of BCG, Corynebacterium parvum, and methanol-extraction residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infection in immunosuppressed mice. Infect. Immun 12, 1325 (1975)

    Google Scholar 

  • Sparks, F. C., Albert, N. E., Andreone, P. A., Breeding, J. H.: Effect of Bacillus Calmette-Guerin on immunosuppression from cyclophosphamide, methotrexate, and 5-fluoruracil. Cancer Res. 37, 2560 (1977)

    Google Scholar 

  • Steven, M., Steven, P., Cook, J. A., Ichinose, H., Di Luzio, N. R.: Protective effect of the immunostimulant glucan on Sporotrichosis infections in mice. J. Reticuloendothel. Soc. 20, 66a (1976)

  • Williams, D. L., Cook, J. A., Hoffmann, E. O., Di Luzio, N. R.: Protective effect of glucan in experimentally induced candidiasis. J. Reticuloendothel. Soc. 23 (6), 479 (1978)

    Google Scholar 

  • Wooles, W. R., Di Luzio, N. R.: Influence of reticuloendothelial hyperfunction on bone marrow transplantation. Am. J. Physiol. 203, 404 (1962)

    Google Scholar 

  • Wooles, W. R., Di Luzio, N. R.: Reticuloendothelial function and the immune response. Science 142, 1078 (1963)

    Google Scholar 

  • Wooles, W. R., Di Luzio, N. R.: The phagocytic and proliferative response of the reticuloendothelial system following glucan administration. J. Reticuloendothel. Soc. 1, 160 (1964)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Di Luzio, N.R., Williams, D.L. Glucan-induced modification of the increased susceptibility of cyclophosphamide-treated mice to Staphylococcus aureus infection. Cancer Immunol Immunother 6, 73–79 (1979). https://doi.org/10.1007/BF00200135

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00200135

Keywords

Navigation